Literature DB >> 34875388

Protective effect of green tea and epigallocatechin-3-gallate in a LPS-induced systemic inflammation model.

Juliana Hofstätter Azambuja1, Rubia Isler Mancuso1, Fernanda Isabel Della Via1, Cristiane Okuda Torello1, Sara Teresinha Olalla Saad2.   

Abstract

Inflammation causes severe dysregulation of organ functions, via the development of oxidative stress and inflammation damage. Polyphenol compounds found in green tea (GTE), including the most important component epigallocatechin-3-gallate (EGCG), have a great therapeutic potential. Here, protective properties of GTE and EGCG against lipopolysaccharide (LPS)-induced inflammation are explored. To this end, the effects of GTE and EGCG were studied on LPS challenged macrophages. Mice received GTE (250 mg/kg/d/p.o) or EGCG (25 mg/kg/d/i.p.) for 7 d, before the inflammation shock was provoked with a single intraperitoneal injection of LPS. The frequencies of lymphocytes CD4+, CD8+, NK1-1+ and CD4+CD25highFOXP3+ (Treg), macrophages CD11b+F480+, monocytes CD11b+Ly6Clow/high, neutrophils CD11b+Ly6G+, MDSCs CD11b+Gr-1high, M2/N2-like phenotype CD206+ and M1-like phenotype CD86+ in spleen, bone marrow and peripheral blood were determined. In vitro studies revealed that GTE and EGCG significantly attenuated LPS-induced CD80 expression and increased the CD163 expression, showing a potential to reduce the macrophage inflammatory phenotype. In vivo, GTE and EGCG inhibited the inflammation, mainly by reducing M1-macrophages and increasing Treg cells in the bone marrow. In addition, GTE and EGCG increase M2-macrophages, N2-neutrophils and Tregs in the spleen and blood and block the migration of monocytes from the bone marrow to the peripheral blood. These findings indicate that EGCG and GTE prevent LPS-induced inflammatory damage contributing to restoring the immune system homeostasis.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epigallocatechin-3-gallate; Green tea; Inflammation; Macrophages; T regulatory lymphocytes, neutrophils and MDSCs

Mesh:

Substances:

Year:  2021        PMID: 34875388     DOI: 10.1016/j.jnutbio.2021.108920

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  6 in total

1.  Combination of Phycocyanin, Zinc, and Selenium Improves Survival Rate and Inflammation in the Lipopolysaccharide-Galactosamine Mouse Model.

Authors:  Pinar Oner; Besir Er; Cemal Orhan; Kazim Sahin
Journal:  Biol Trace Elem Res       Date:  2022-09-29       Impact factor: 4.081

2.  Tea Ingredients Have Anti-coronavirus Disease 2019 (COVID-19) Targets Based on Bioinformatics Analyses and Pharmacological Effects on LPS-Stimulated Macrophages.

Authors:  Lei Wang; Qing Tao; Zhiguo Wang; Jianfeng Shi; Wei Yan; Li Zhang; Yaoxiang Sun; Xiaoming Yao
Journal:  Front Nutr       Date:  2022-05-20

3.  Epigallocatechin-3-Gallate Ameliorates Acute Lung Damage by Inhibiting Quorum-Sensing-Related Virulence Factors of Pseudomonas aeruginosa.

Authors:  Huaqiao Tang; Suqi Hao; Muhammad Faraz Khan; Ling Zhao; Fei Shi; Yinglun Li; Hongrui Guo; Yuanfeng Zou; Cheng Lv; Jie Luo; Ze Zeng; Qiang Wu; Gang Ye
Journal:  Front Microbiol       Date:  2022-04-25       Impact factor: 6.064

Review 4.  Non-Celiac Gluten Sensitivity and Protective Role of Dietary Polyphenols.

Authors:  Nadia Calabriso; Egeria Scoditti; Marika Massaro; Michele Maffia; Marcello Chieppa; Barbara Laddomada; Maria Annunziata Carluccio
Journal:  Nutrients       Date:  2022-06-28       Impact factor: 6.706

Review 5.  Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG): A Time for a New Player in the Treatment of Respiratory Diseases?

Authors:  Daniela Mokra; Jana Adamcakova; Juraj Mokry
Journal:  Antioxidants (Basel)       Date:  2022-08-13

6.  Preventive Effect of Epigallocatechin Gallate, the Main Component of Green Tea, on Acute Lung Injury Caused by Air Pollutants.

Authors:  Ken-Ichiro Tanaka; Shunsuke Nakaguchi; Sachie Shiota; Yuka Nakada; Kaho Oyama; Okina Sakakibara; Mikako Shimoda; Akio Sugimoto; Masaki Ichitani; Takanobu Takihara; Hitoshi Kinugasa; Masahiro Kawahara
Journal:  Biomolecules       Date:  2022-08-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.